Methylenedioxyhydroxylmethamphetamine

Methylenedioxyhydroxylmethamphetamine (MDHMA) is a psychoactive drug and a substituted amphetamine derivative. It is structurally related to 3,4-methylenedioxy-N-methylamphetamine (MDMA), a widely used recreational drug known commonly as ecstasy.

Chemistry

MDHMA is a ring-substituted amphetamine derivative, and it shares the core amphetamine structure. However, it differs from amphetamine due to the presence of a methylenedioxy group attached to the phenyl ring and a hydroxyl group attached to the alpha carbon.

Pharmacology

The pharmacological effects of MDHMA are not well-studied. However, it is believed to act as a serotonin-norepinephrine-dopamine releasing agent (SNDRA), similar to its structural analog, MDMA. This means it promotes the release of these neurotransmitters in the brain, which can lead to various psychological and physiological effects.

Effects

The effects of MDHMA are largely unknown due to the lack of scientific research. However, based on its structural similarity to MDMA, it is speculated that it may produce similar effects, such as feelings of euphoria, increased sociability, and altered sensory perception.

Legal Status

The legal status of MDHMA varies by country. In many jurisdictions, it is considered a controlled substance due to its structural similarity to MDMA.

See Also

• MDMA
• Amphetamine
• Psychoactive drug
• Controlled substance

References

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian